Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplantation

NCT00597714 is registered in ClinicalTrials.gov with David Rizzieri, MD as lead sponsor.

NCT NCT00597714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00597714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplantation
Lead sponsor
David Rizzieri, MD
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
November 30, 2013
Enrollment
264 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's disease, leukemia, myelodysplasia, myeloma, non hodgkin's lymphoma